Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study

BJOG. 2017 Oct;124(11):1680-1687. doi: 10.1111/1471-0528.14614. Epub 2017 Apr 5.

Abstract

Objectives: To analyse whether the prevalence of undiagnosed HIV among (1) all women in Sweden and (2) migrant women, diagnosed with cervical intraepithelial neoplasia grade 2 or worse CIN2+ reaches the threshold of 0.1%, which has been suggested to be cost-effective for HIV testing.

Design: Population-based register study.

Setting: Counties of Stockholm and Gothenburg, Sweden, 1990-2014.

Population: All women, born between 1940 and 1990, with at least one cervical cytology or histology registered in the Swedish National Cervical Screening Register (NKCx).

Methods: Data were collected from the NKCx and the Swedish National HIV register. The proportion of women with undiagnosed HIV among women with CIN2+ compared with women with a normal/mildly abnormal cytology/histology was assessed.

Main outcome measures: Proportion of women with undiagnosed HIV.

Results: The proportion of undiagnosed HIV was higher among all women with CIN2+ than among those without CIN2+ : 0.06% (95% CI 0.04-0.08) versus 0.04% (95% CI 0.04-0.04); P = 0.017). Among migrant women, the proportion of undiagnosed HIV was higher among those with CIN2+ than among those without [0.30% (95% CI 0.20-0.43) versus 0.08% (95% CI 0.07-0.10); P < 0.001] and exceeded 0.1%, suggesting the cost-effectiveness of HIV testing. Women with undiagnosed HIV at the time of CIN2+ had a significantly lower nadir CD4+ T-cell count, as a measure of immunosuppression, compared with women without CIN2+ before HIV diagnosis (median nadir CD4, 95 cells/mm3 versus 210 cells/mm3 ; P < 0.01).

Conclusions: HIV testing should be performed in migrant women with unknown HIV status diagnosed with CIN2+ .

Tweetable abstract: HIV testing should be performed in migrant women with unknown HIV status diagnosed with CIN2+ .

Keywords: Cervical intraepithelial neoplasia; HIV; indicator disease; migrants.

MeSH terms

  • Adult
  • Aged
  • Cervix Uteri / virology*
  • Cohort Studies
  • Cost-Benefit Analysis
  • Female
  • HIV Infections / diagnosis*
  • HIV Infections / economics
  • HIV Infections / epidemiology
  • HIV Infections / immunology
  • Humans
  • Mass Screening / economics*
  • Middle Aged
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / economics
  • Papillomavirus Infections / epidemiology
  • Sweden / epidemiology
  • Transients and Migrants / statistics & numerical data*
  • Uterine Cervical Dysplasia / diagnosis*
  • Uterine Cervical Dysplasia / economics
  • Uterine Cervical Dysplasia / epidemiology
  • Vaginal Smears / statistics & numerical data*